[Mitoxantrone HCl (1,4-dihydroxy-4, 8-bis[[2-(hydroxyethyl)-amino-ethyl)]amino 9,10-anthracenedione dihydrochloride (NSC 301739) - a new cytostatic].
D000818:Animals; D000873:Anthracenes / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D000882:Haplorhini; D006801:Humans; D051379:Mice; D008942:Mitoxantrone; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy
D000873:Anthracenes; D000970:Antineoplastic Agents; D008942:Mitoxantrone
Mitoxantrone HCL (1.4-Dihydroxy-5,8-bis[[2-(hydroxyäthyl)-amino-äthyl)]amino 9,10 - anthrazendion dihydrochlorid (NSC 301739) - ein neues Zytostatikum.